通过剂量升级方法成功使用 cetuximab:一个案例报告
Shasha Li1, Yanjuan Zhang2, Jiandong Zha3
1Department of Clinical Oncology, The University of Hong Kong Shenzhen Hospital, Shenzhen, China. liss7@hku-szh.org.
Journal of medical case reports
|October 16, 2024
概括
超敏感性可以被管理. 一个剂量升级策略与预治疗和监测允许在患有转移性结直肠癌的患者安全使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 塞图西马布是治疗头角状细胞癌和转移性结直肠癌的关键疗法.
- 严重的输液反应是 cetuximab 治疗的已知不良影响.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
